B
B

BayerAG


News

African Union crafts guidelines for GM crops, activists raise alarm

* New push for harmonisation of GMO regulations in Africa * Only seven African countries have commercial GM output * Backers of GM crops says they will improve food security * Critics raise safety concerns, say poor farmers will suffer By Wendell Roelf CAPE TOWN, Aug 31 (Reuters) - The African Union is developing guidelines for the use of genetical
B

European shares notch fourth straight record high on earnings strength

* Novo Nordisk among top boosts * Zalando, Adidas knock down retail sector * Mining stocks down on Chinese demand fears * BoE outlines plans for reducing stimulus By Sruthi Shankar and Ambar Warrick Aug 5 (Reuters) - European stocks ended at record highs on Thursday, as strong results from Novo Nordisk and Siemens helped outweigh weak mining stocks
A
B
B
E
S
Z
G
E
F
U

CureVac 19 vaccine records only 48% efficacy in final trial readout

By Ludwig Burger June 30 (Reuters) - CureVac 5CV.DE said its COVID-19 vaccine was 48% effective in the final analysis of its pivotal mass trial, only marginally better than the 47% reported after an initial read-out two weeks ago. The German biotech firm said that efficacy, measured by preventing symptomatic disease, was slightly better at 53% when
B
G
N
P

CureVac may let contractors make rival vaccines if own shot fails -CEO

By Tilman Blasshofer and Ludwig Burger FRANKFURT, June 17 (Reuters) - German biotech firm CureVac 5CV.DE could allow its network of manufacturing partners to be repurposed to make vaccines developed by other companies should its own experimental shot fail, its chief executive told Reuters on Thursday. The German company saw billions of euros wiped
B
G
N
P
W

Swiss reject law to help country meet Paris carbon emissions goal

* Swiss voted on five issues in national referendums * New CO2 Law to help cut carbon emissions narrowly rejected * Voters against proposals to ban pesticides or reduce use * New terrorism laws which could affect 12-year-olds approved By John Revill ZURICH, June 13 (Reuters) - Swiss voters rejected a trio of environmental proposals on Sunday, inclu
B

Swiss voters look set to reject law to help cut carbon emissions

(Repeating to say pix are available, no changes to text) ZURICH, June 13 (Reuters) - Swiss voters look set to reject a new law which would help the country meet its goals under the Paris Agreement on Climate Change, according to early indications by national broadcaster SRF on Sunday. Projections showed 51% of voters had voted against the new CO2 l
B
B

Swiss voters look set to reject law to help cut carbon emissions

ZURICH, June 13 (Reuters) - Swiss voters look set to reject a new law which would help the country meet its goals under the Paris Agreement on Climate Change, according to early indications by national broadcaster SRF on Sunday. Projections showed 51% of voters had voted against the new CO2 law in a nationwide referendum conducted under the country
B
B

Many German firms have no women on boards despite quota, study shows

BERLIN, May 27 (Reuters) - The number of women in German boardrooms is only rising slowly despite legal quotas and many large listed German companies have no women on their management teams, a study showed on Thursday. Of the 66 listed firms subject to a new quota for executive management, including 30 on the DAX blue-chip index, 25 have no women o
A
B
E
I

European shares hit record high on Airbus boost, Bayer hurt by Roundup ruling

* Mining stocks, banks were best performers * Airbus jumps on hiking jet output targets * Food and beverage stocks hurt by Tate & Lyle By Ambar Warrick and Shreyashi Sanyal May 27 (Reuters) - European shares closed at a record high on Thursday boosted by Airbus after the planemaker hiked its jet output targets, while German shares weakened after sh
A
B
H
K
P
T
G
E
F
U

Stinkweed to false flax: oilseeds race to reap biofuel bonanza

By Karl Plume and Rod Nickel ARENZVILLE, Illinois, May 26 (Reuters) - A disparate group met in an Illinois field on a windy spring morning to study a crop some call stinkweed. Botanists, businessmen, farmers and federal lawmakers, they all gathered to peer at the waist-high plant usually considered a pest and uprooted on sight because of its foul o
B

EU top court upholds ban on Bayer pesticides linked to harming bees

By Kate Abnett BRUSSELS, May 6 (Reuters) - The European Union's top court on Thursday upheld the EU's partial ban on three insecticides linked to harming bees, preventing their use on certain crops. The European Court of Justice dismissed an appeal by Bayer BAYGn.DE to overturn a lower EU court's 2018 decision to uphold the ban. The ruling covers t
B

EU top court upholds EU ban on Bayer pesticides linked to harming bees

BRUSSELS, May 6 (Reuters) - The European Union's top court on Thursday upheld the EU's partial ban on three insecticides linked to harming bees, preventing their use on certain crops. The European Court of Justice, on Thursday dismissed an appeal by Bayer to overturn a lower EU court's 2018 decision to uphold the EU ban. The ruling covers three act
B
P

Farmers struggle to break into booming carbon-credit market

By Karl Plume April 28 (Reuters) - When Microsoft Corp MSFT.O made a massive purchase of carbon credits in January, it turned to a relatively new source: farmers who plant crops meant to trap carbon in the soil. The credits are financial instruments generated by projects that reduce or avoid the release of greenhouse gases, such as solar farms or t
B
M
N

Big business seeks unified, market-based approaches ahead of climate summit

By Ross Kerber and Simon Jessop April 15 (Reuters) - Corporate executives and investors say they want world leaders at next week's climate summit to embrace a unified and market-based approach to slashing their carbon emissions. The request reflects the business world's growing acceptance that the world needs to sharply reduce global greenhouse gas
B
V

Big business seeks unified, market-based approaches ahead of climate summit

By Ross Kerber and Simon Jessop April 15 (Reuters) - Corporate executives and investors say they want world leaders at next week's climate summit to embrace a unified and market-based approach to slashing their carbon emissions. The request reflects the business world's growing acceptance that the world needs to sharply reduce global greenhouse gas
B
V

As vaccine nationalism deepens, governments pay to bring production home

By Caroline Copley, Andreas Rinke and Allison Martell DESSAU, Germany, March 12 (Reuters) - In the German town of Dessau, one of the sites of the Bauhaus art school, an institute was set up in 1921 to mass-produce vaccines that later helped strengthen the German Democratic Republic. Exactly 100 years later, the site is gearing up to be a one-stop s
A
B
L
P
S

Novartis joins CureVac's vaccine contractor line-up

* Trial read-out expected early in second quarter * Other partners include Bayer, GSK, Fareva, Rentschler * Novartis site to come online in summer of 2021 * Novartis to make up to 50 mln doses this year By Ludwig Burger FRANKFURT, March 4 (Reuters) - German biotech firm CureVac 5CV.DE has enlisted Swiss pharmaceutical giant Novartis NOVN.S to help
B
G
N
W

German cabinet approves legislation to ban glyphosate from 2024

BERLIN, Feb 10 (Reuters) - Farmers in Germany will have to gradually reduce their use of glyphosate and stop using it completely from 2024 in order to preserve clean habitats for insects, under draft legislation passed by the country's cabinet on Wednesday. "The exit from glyphosate is coming. Conservationists have been working toward this for a lo
B

Disappointing earnings updates weigh on FTSE 100; Italian shares shine

* German ruling parties agree extra economic support measures * Bayer jumps on future Roundup cancer claims deal * Unilever slides on underwhelming sales growth target * BOE pushes out negative interest rate timeline (Updates to close) By Shreyashi Sanyal and Susan Mathew Feb 4 (Reuters) - European shares extended their rally to a fourth straight d
B
G
G
E
F
I
U

GSK, CureVac team up to develop vaccine against 19 variants

* 150 mln eur deal to develop next-generation vaccines * GSK to also help produce 100 mln doses of CureVac's vaccine * GSK has suffered setbacks in COVID-19 vaccine development By Ludwig Burger FRANKFURT, Feb 3 (Reuters) - Britain's GlaxoSmithKline GSK.L and German biotech firm CureVac 5CV.DE have teamed up in a 150 million euro ($180 million) deal
B
G
S



Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.